Physician profile
David Hoang
NPI 1023671567
$1,883.13
in general payments reported to CMS, 2019-2025
25 companies · $39.30 in 2025
The $39.30 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,812 · 2022: $12.68 · 2024: $18.96 · 2025: $39.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $220.07 | 2021 | |
| Amgen INC. | $189.71 | 2021-2024 | Tepezza |
| Abbvie INC. | $185.51 | 2021 | |
| Lilly USA, LLC | $152.36 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $121.91 | 2021 | |
| Amarin Pharma, INC. | $120.78 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.53 | 2021 | |
| Glaxosmithkline, LLC. | $112.03 | 2021 | |
| Merck Sharp & Dohme LLC | $72.97 | 2021 | |
| Adlon Therapeutics L.P. | $61.26 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.08 | 2021 | |
| Sanofi-Aventis U.S. LLC | $54.42 | 2021 | |
| Vivus LLC | $53.42 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.73 | 2021 | |
| Janssen Pharmaceuticals, INC | $52.58 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $45.29 | 2021 | |
| Paratek Pharmaceuticals, INC. | $43.27 | 2021-2022 | |
| Ethicon US, LLC | $39.30 | 2025 | Stratafix, Vistaseal |
| Dexcom, INC. | $33.51 | 2021 | |
| Phadia US INC. | $21.81 | 2021 | |
| Genentech USA, INC. | $19.98 | 2021 | |
| Horizon Therapeutics Plc | $16.39 | 2021 | |
| Arbor Pharmaceuticals, INC. | $16.23 | 2021 | |
| Currax Pharmaceuticals LLC | $14.79 | 2021 | |
| Sunovion Pharmaceuticals INC. | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hoang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.